Skip to main
  • Published

From Donor to Recipient: Navigating the Challenges of Donor-Derived Infections in Solid Organ Transplantation

Hosted and organized by AST Transplant Pharmacy (TxPharm COP) and Infectious Disease (IDCOP) Communities of Practice.

This webinar focuses on donor-derived infections in solid organ transplantation, highlighting both expected and unexpected infectious risks from donor to recipient. Recorded on December 11, 2025, the session provides a practical, case-based approach to identifying, stratifying, and managing donor-derived infections in transplant recipients.

Key topics include donor-derived infection risk stratification, mitigation strategies in organ transplantation, and clinical decision-making for unexpected donor-transmitted infections. Designed for transplant clinicians, infectious disease specialists, pharmacists, and transplant care teams, this webinar emphasizes real-world application and patient safety.

Objectives:

  1. Provide an overview of donor derived infections (expected versus unexpected)
  2. Develop guidance for risk stratification and mitigation for donor derived infections
  3. Review a case-based approach to identifying and managing patients with unexpected donor derived infections

Speakers:

  • Ann Woolley, MD – Brigham and Women's Hospital

  • Silke Niederhaus, MD – University of Maryland Medical Center

  • Miranda So, PharmD – University Health Network, Canada

Moderator:

  • Edith Ford, PharmD – Prisma Health, South Carolina

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi